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Abstract
Three known (leoleorins A-C) and eight new (leoleorins D-J and 16-epi-leoleorin F) labdane
diterpenoids, were isolated from leaves of Leonotis leonurus. The absolute configurations of
leoleorins A and D were established by X-ray crystallographic analyses. In competitive binding
assay all isolated compounds showed inhibition in excess of 50% at various CNS receptors.
Leoleorin C showed moderate binding affinity (Ki = 2.9 μM) for the Sigma 1 receptor.
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1. Introduction
Leonotis leonurus (L.) R. Br. (Lamiaceae), also known as Lion's Tail or Wild Dagga, is
commonly used in Southern Africa to treat fevers, headaches, dysentery, flu, chest
infections, epilepsy, constipation, delayed menstruation, intestinal worms, spider bites,
scorpion stings, hypertension, and snake bites (Iwarsson, 1985; Stafford et al., 2008). It is
also known for its mild psychoactive properties. The dried leaves and flowers have a mild
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calming effect when smoked, which is similar to the effect of the THC cannabinoid found in
Cannabis. It has also been reported to cause mild euphoria, visual changes, dizziness,
nausea, sweating, sedation, and light headedness. The picked and dried leaves are also
commonly brewed as a minty tea. Research showed that it could be used to benefit people
with anxiety and depression due to its calming effects. L.leonurus has been proposed to
modulate dopaminergic system (Stafford et al., 2008). Water and lipid extracts of the leaves
showed anticonvulsant (Bienvenu et al., 2002), antinociceptive (Ojewole, 2005), anti-
inflammatory (Ojewole, 2005; Stafford et al., 2005), antidiabetic (Ojewole, 2005; Oyedemi
et al., 2011), antibacterial (Stafford et al., 2005; Scott et al., 2004; Jimoh et al., 2010), anti-
oxidant (Jimoh et al., 2010; Frum and Viljoen, 2006), and anthelmintic (Maphosa et al.,
2010) activities.
Previous phytochemical analysis of extracts of L. leonurus indicated the presence of tannins,
alkaloids, as well as steroidal and triterpenoid saponins (Bienvenu et al., 2002). Organic
extracts of the flowering parts of the plant provided flavonoids and acyclic diterpene esters
(El-Ansari et al., 2009; Agnihotri et al., 2009), while the leaves contained mostly labdane
diterpenoids (Cragg and Little, 1962; Rivett, 1964; Kaplan and Rivett, 1968; Laonigro et al.,
1979; Kruger and Rivett, 1988; McKenzie at al., 2006; Obikeze et al., 2008; Naidoo et al.,
2011). Herein, the isolation and structure elucidation of eight new (1-8) and three known
(9-11) labdane diterpenoids (Fig. 1) from this species are reported. In collaboration with the
National Institute of Mental Health Psychoactive Drug Screening Program (NIMH-PDSP),
in vitro receptor screening of all pure isolates resulted in identification of the active
constituents of L. leonurus.
2. Results and discussion
2.1 Structural elucidation of compounds
A Leoleorin D (1), was obtained as colorless crystals,  −7.5, and was established to
have a molecular formula of C20H36O4 by HR-ESIMS (m/z 363.2499 [M + Na]+). In the 1H
NMR spectrum, singlets representing three tertiary methyl groups at δH 1.01, 1.24, and 1.27,
and a doublet of one secondary methyl group at δH 0.93 (J = 6.8 Hz) were evident. The 13C
NMR and DEPT spectra exhibited 20 carbon resonances (4 × C, 3 × CH, 9 × CH2, and 4 ×
CH3). There were signals of two oxygenated quaternary carbons at δC 94.1 and 85.3,
characteristic features of the oxygenated carbon of a spirotetrahydrofuran moiety, two
oxymethylene groups [δC 66.8; δH 3.50 (H-16a, d, J = 10.8 Hz) and δH 3.62 (H-16b, d, J =
10.8 Hz); δC 59.6; δH 3.85 (H2-15, m)], and one oxymethine group [δC 68.0; δH 4.36 (br s)].
The molecular formula requiring three degrees of unsaturation, in conjunction with the
absence of UV absorption and sp2 or sp carbon resonances, suggested a highly oxygenated
tricyclic labdane diterpenoid skeleton for 1, similar to the structure of lagochilin (Chizhov et
al., 1979). In the HMBC spectrum, correlations of H-6 with C-4, C-5, C-7, C-8, C-10,
Me-17 with C-7, C-8, C-9, Me-20 with C-1, C-5, C-9, C-10, as well as Me-18 and Me-19
with C-3, C-4, and C-5, were used to assign the hydroxy group to C-6. The known α-
orientation of H-5 in labdane diterpenoids (Wu et al., 2011), and the coupling profile (br s)
of H-5 and H-6 indicated the cis-arrangement of these two protons in an α-axial, α-
equatorial orientation, with the 6-OH β-axially oriented. Thus, the structure of 1 was
proposed as 9,13-epoxylabdane-6β,15,16-triol. X-ray crystallographic data of 1 (Fig. 2)
further defined its absolute configuration and structure as (5S,6R,8R,9R,10S,13S)-9,13-
epoxylabdane-6,15,16-triol.
Leoleorin E (2), was isolated as a colorless oil,  −3.3, and its molecular formula was
determined to be C20H34O4 by HR-ESIMS (m/z 361.2351 [M + Na]+). The 1H and 13C
NMR spectroscopic data (Tables 1 and 2) indicated the presence of a C-15 hemiacetal
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carbon (δC 98.9, CH; δH 5.41, d, J = 4.8 Hz) rather than a C-16 hemiacetal, due to the
presence of the H2-16 resonances at δH 3.55 (d, J = 8.8 Hz) and 4.27 (d, J = 8.8 Hz). The
HMBC correlations showed similar relationships as in 1, except for the presence of
correlations between H2-16 and C-15, and H2-15 and C-16. The relative configuration of 2
was assigned on the basis of NOESY correlations (Fig. 3). Based on the assumed 5S
configuration for labdane diterpenoids and the NOEs between Me-17 and H2-14 and
between H-16a (δH 4.27) and H-1α (δH 1.89), which are consistent with a 13S configuration
of the spirocyclic D-ring. The β-orientation of H-15 was concluded from a NOESY
correlation between H-15 and H-12β (δH 1.92, m). The NOESY spectrum showed
correlations of Me-18 (δH 0.97, s) with H-5 (δH 1.31) and H-6 (δH 4.34), indicating the
proximity of these protons. Since Me-18 and H-5 in labdanes are α-oriented, H-6 will be α-
equatorial. Consequently, the 6-OH has a β-axial orientation. Based on these data, 2 was
identified as 9,13:15,16-diepoxylabdane-6β,15α-diol.
Leoleorin F (3) was isolated as a colorless oil,  −21.6, and its molecular formula was
determined to be C20H34O4 by HR-ESIMS (m/z 361.2357 [M + Na]+). The 1H and 13C
NMR (Tables 1 and 2), and HSQC data confirmed the presence of three tertiary methyl
groups [δH 1.24 (s), 1.20 (s), and 0.97 (s)], one methyl doublet at δH 0.88 (d, J = 6.8 Hz),
two oxygenated quaternary carbons (δC 94.3, 90.6), one oxymethylene group [δC 64.9; δH
4.09 (m), 3.77 (m)], and a hemiacetal group [δC 98.8; δH 4.70 (s) ]. With four degrees of
unsaturation and the absence of sp2 or sp carbon resonances and UV absorption, compound
3 should be a labdane diterpenoid with a spirotetrahydrofuran structural moiety. The NMR
spectroscopic data are similar to those of 9,13:15,16-diepoxylabdane-6β,16-diol (Naidoo et
al., 2011), which has been identified as an α, β anomeric mixture at C-16 with the
configuration of C-13 undetermined. In the NOESY spectrum (Fig. 4), NOEs were detected
between Me-18 (δH 0.97) and H-5 (δH 1.33), Me-18 and H-6 (δH 4.34), Me-20 (δH 1.24)
and H-11 (δH 2.14, 2.09), Me-20 and H-8 (δH 2.11) establishing the relative configurations
at C-5, C-6, C-8, C-9, and C-10. Similarly to compound 2, the configuration at C-13 was
determined as S from the NOE correlations between H-1α (δH 1.47) and H-16 (δH 4.70),
between H-14 (δH 2.35) and Me-17 (δH 0.88), and the latter also confirmed the α-
orientation of Me-17. Therefore, the structure of 3 was identified as 9,13:15,16-
diepoxylabdane-6β, 16β-diol.
16-epi-Leoleorin F (4), was isolated as a white powder, and its molecular formula C20H34O4
was determined to be same as that of 3 by HR-ESIMS (m/z 361.2359 [M + Na]+). The 1H
and 13C NMR spectroscopic data (Tables 1 and 2) were very close to those of 3. The major
difference between 3 and 4 is the opposite sign of their specific rotation (  +30.0 for 4,
and −21.6 for 3), and the opposite configuration of C-16 in 4 as indicated by NOESY
correlations (Fig. 5). Thus 4 was identified as a C-16 epimer of 3, 9,13:15,16-
diepoxylabdane-6β,16α-diol.
Leoleorin G (5) was obtained as a colorless oil,  −20.5, and its molecular formula was
determined as C20H28O4 by HR-ESIMS (m/z 355.1889 [M + Na]+). Its UV maximum
absorbance was at 233 nm. The 13C NMR and DEPT spectra (Table 2) showed 20 carbon
resonances indicating four methyl, seven methylene (one oxymethylene at δC 77.8), two
methine (including one olefinic carbon), and seven quaternary carbons. Analysis of the
NMR spectroscopic data (Tables 1 and 2) established the characteristic features of an α, β-
unsaturated carbonyl moiety [δC 172.6 (C-5), 123.0 (C-6), 199.2 (C-7); δH5.93 (s, H-6 )]
analogous to that present in compound Y, which was previously isolated from the same
species (Kaplan and Rivett, 1968). Additionally, the HMBC spectrum showed correlations
of H2-16 [δH 4.14 (d, J = 8.8), 3.99 (d, J = 8.8)] and H2-14 [δH 2.80 (d, J = 17.2), 2.43 (d, J
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= 17.2)] with the carbonyl carbon at δC 174.2, indicating the presence of a five-membered
lactone ring. Thus structure 5 was determined to be 9,13-epoxylabd-5-en-7-on-15,16-olide.
Leoleorin H (6), was isolated as a white powder (  −29.5) that gave an [M + H]+ ion at
m/z 379.2468 in HR-ESIMS, consistent with a molecular formula of C22H34O5, requiring
six degrees of unsaturation. The similarity of the UV spectra of 6 and 5 suggested the
presence of an α,β-unsaturated carbonyl moiety in 6, which was also consistent with the
NMR spectroscopic data (Tables 1 and 2) of the conjugated carbonyl unit [δC 172.3 (C-5),
122.9 (C-6), 199.9 (C-7); δH 5.90 (H-6, s)]. Twenty two resonances (7 × C; 2 × CH; 8 ×
CH2; 5 × CH3) were observed in the 13C NMR and DEPT spectra (Table 2). The signals of
an acetoxy group [δC 171.1 (CH3C=O), 20.9 (CH3C=O); δH 1.90 (3H, s)] were observed.
The HMBC correlation between the acetate carbonyl carbon (δC 171.1) and oxymethylene
protons [δH 3.93 (2H, m), H2-15], and the absence of HMBC correlation between the
oxymethylene group at δH 3.29 (1H, d, J = 11.2), 3.38 (1H, d, J = 11.2) and the acetoxy
carbonyl carbon (δC 171.1), showed a seco-type arrangement similar to compound 1, in
which the hydroxy group at C-15 was acetylated. Thus, 6 was identified as 15-acetoxy-9,13-
epoxy-16-hydroxylabd-5-en-7-one.
Leoleorin I (7), was obtained as a colorless oil,  −36.5, and its molecular formula was
determined as C20H32O4 by HR-ESIMS (m/z 359.2208 [M + Na]+). The 1H and 13C NMR
spectroscopic data (Tables 1 and 2), DEPT, HMBC, HMQC and specific rotation of 7 and 6
were similar, except for the absence of resonances for the acetyl group in 7. Thus, 7 was
identified as 9,13-epoxy-15,16-dihydroxylabd-5-en-7-one.
Leoleorin J (8), was obtained as a colorless oil,  −69.6, and its molecular formula was
determined as C20H34O4 by HR-ESIMS (m/z 361.2359 [M + Na]+). The 1H and 13C NMR
(Tables 1 and 2), and UV spectra showed that the conjugated carbonyl moiety in 7 was
replaced by an allylic alcohol functionality [δH 5.57 (d, J = 1.6 Hz, H-6), 3.95 (dd, J = 9.2,
1.6 Hz, H-7); δC 150.2 (C-5), 122.5 (C-6), 72.1 (C-7)] in the structure of 8. Judging from the
molecular formula and putative bio synthetic origin, 8 may be produced by enzymatic
reduction of 7 to the corresponding allylic alcohol derivative, or obtained from 1 by
dehydration followed by an allylic oxidation. The β-orientation of the 7-OH group was
deduced from the NOESY correlation between H-7 (δH3.95, 1H, dd, J = 9.2, 1.6) and Me-17
(δH 1.12, 3H, d, J = 6.8). Thus, 8 was identified as 9,13-epoxylabd-5-ene-7β,15,16-triol.
The remaining three compounds 9–11 were earlier reported as compound Y (Kaplan and
Rivett, 1968), 9,13-epoxy-6-hydroxylabdan-15,16-olide (Naidoo et al., 2011), and semi-
synthetic derivative anhydro-Y (Cragg and Little, 1962; Kaplan and Rivett, 1968). Because
of their structural similarity to compounds 1–8, renaming of their names to leoleorins A-C is
proposed. Leoleorin A (9) was obtained as white crystals,  −22.5, and its ESIMS
spectrum gave an ion peak at m/z 317.2 ([M + H]+). Since leoleorins A (9) and B (10) were
reported (Cragg and Little, 1962; Kaplan and Rivett, 1968) before the advent of high
resolution NMR instruments their 1H and 13C NMR assignments are presented here. The 1H
NMR spectrum of 9 (Table 1) exhibited the typical proton resonances of a β-substituted
furan moiety at δH 7.35, 7.23, and 6.28, three methyl singlets at δH 1.36, 1.23, and 1.18, and
one methyl doublet at δH 1.28 (J = 6.8 Hz), coupled with a vicinal proton (2.78, q, J = 6.8
Hz). The signals of an α,β - unsaturated carbonyl moiety were observed at δH 6.12 (s, H-6),
and δC 175.3 (C-5), 123.7 (C-6), 200.1 (C-7), which is in agreement with the UV absorption
at 240 nm. The structure and absolute configuration of 9 were unambiguously defined by
single-crystal X-ray crystallography as (8S,9R,10S)-15,16-epoxy-9α-
hydroxylabda-5,13(16),14-trien-7-one (Fig. 6)(Kaplan and Rivett, 1968).
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Leoleorin C (10) was isolated as a yellow oil,  +23.9. Comparison of the NMR
spectroscopic data of 10 with those of 9 showed two additional sp2 carbon signals at δC
130.8 and 163.1, and replacement of the Me-17 doublet with singlet (δH 1.95) in the
spectrum of compound 10. These features suggested that 10 might derive from 9 via
dehydration with formation of C-8 – C-9 double bond. Based on these data, compound 10
was identified as 15,16-epoxylabda-5,8,13(16),14-tetraen-7-one, which is identical with
anhydro-Y obtained semi-synthetically from compound Y (Kaplan and Rivett, 1968).
2.2 Binding affinities of isolated compounds to CNS receptors
Compounds (1 – 11) were screened against a battery of 26 G-protein-coupled receptors
including serotonin, adrenergic, dopamine, histamine, muscarinic acetylcholine, and opioid
receptors. Additionally, the compounds were screened against biogenic amine transporters
and the sigma1 and sigma2 receptors. The data (Table 3) demonstrate that some of the
compounds displayed activity in several assays. Compounds 1, 6, 7, and 9 inhibited
radioligand binding at the serotonin 5-HT1A receptor (inhibition: 62.3, 50.0, 61.9, and
60.4%, respectively), while compound 8 showed 57.0% inhibition at the 5HT3 receptor.
Compounds 1, 2, 5, and 6 showed activity at the D1-dopamine receptor (inhibition: 50.3,
57.4, 62.3, and 55.7 %, respectively). Compounds 2, 3, 10, and 11 showed significant
activity at the H1-histamine receptor (inhibition: 54.8, 56.3, 52.3, and 63.2%, respectively).
In addition, compounds 4 and 11 inhibited binding at the M3-acetylcholine, and sigma-1
receptors (inhibition: 55.1, and 59.1 %, respectively). In the secondary assay of competitive
binding compound 11 showed moderate affinity (Ki = 2.9 μM as compare to positive
control, haloperidol Ki=7 nM) for the Sigma 1 receptor. In all other assays, the compounds
displayed Ki values > 10,000 nM and were not pursued further.
2.3 Concluding remarks
Eight labdane diterpenoids (1–8) together with three known compounds (9–11), were
isolated from leaves of L. leonurus. Their structures were established on the basis of
spectroscopic methods as well as X-ray crystallographic analyses. In the radioligand binding
assay, leoleorin C (11) showed moderate binding affinity (Ki = 2.9 μM) to the Sigma 1
receptor, which could be responsible for the psychoactive properties of this plant.
Many labdane diterpenoids were previously isolated from L. leonurus as well as other
Leonotis species, and they may therefore serve as chemical markers for characterization of
the Leonotis genus. In the current study, compounds 1–8 were obtained as new compounds
in relatively high concentrations; their presence being overlooked in previous investigations
is presumably attributable to variations of harvest time, geographical, climate, and
environmental factors.
3. Experimental
3.1 General Experimental Procedures
Melting points were measured on OptiMelt MPA100 Automated Melting Point System and
are uncorrected. Optical rotations were acquired with a Rudolph Research Analytical
Autopol IV automatic polarimeter. IR spectra were recorded on a Bruker Tensor 27
spectrophotometer. NMR spectra were acquired on a Bruker DRX NMR spectrometer
operating at 400 MHz for 1H and 100 MHz for 13C with a 3 mm direct carbon probe. The
mass detector was time of flight (model G1969A) equipped with an electrospray ionization
interface and was controlled by Aligent software (Aligent Mass Hunter Work Station, A.
02.01).
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Leafy freeze-dried material of L. leonurus was purchased from IAmShaman Shop (P.O. Box
12618 Chicago, IL 60612) in June 2010, and authenticated by one of the co-authors (Charles
Burandt Jr.). A voucher specimen (Code: hkwu-LL-20101006) was deposited at the
Department of Pharmacognosy, School of Pharmacy, University of Mississippi.
3.3 Extraction and Isolation
The dried and powdered leaves of L. leonurus (411 g) were extracted with acetone (3×2.0 L;
each 24 h) by percolation at room temperature. The solvent was evaporated under reduced
pressure at 40 °C to yield 42 g (10.2 %) of a viscous syrup, which was dissolved in
CH2Cl2:MeOH (60 mL, 1:1, v/v) and mixed with silica gel (85 g, 200–300 mesh), and dried
at room temperature in a rotary evaporator under reduced pressure to give a fine powder.
The latter was separated by silica gel column chromatography (CC) (200 g), eluted with
hexanes-EtOAc (10:1, 4:1, 2:1, 1:1, 1:4, and 0:1, v/v) to give six sub-fractions A - F. Fr. A
(3.1 g) containing fatty acids and pigments, was not studied further. Fr. B (9.5 g) was
purified by Sephadex LH-20 (CH2Cl2-MeOH 1:1), and then silica gel CC (100 g), eluted
with hexanes-EtOAc (9:1, 7:1, 5:1, 3:1, v/v) to yield 9 (1 g), 3 (1 g), 11 (22 mg) and 10 (40
mg), respectively. Fr. C (2.8 g) was purified by silica gel CC (100 g), eluted with hexanes-
EtOAc (5:1, 4:1, 3:1, 2:1,v/v) to yield 4 (630 mg) and 2 (100 mg). Fr. D (5 g) was purified
by silica gel CC (100 g), eluted with hexanes-EtOAc (3:1, 2:1, 1:1,v/v) to yield 5 (500 mg)
and 6 (200 mg). Fr. E (5.0 g) was purified by silica gel CC (160 g), eluted with hexanes-
EtOAc (3:1, 2:1, 1:1,v/v) to yield 1 (300 mg). Fr. F (2 g) was purified by Sephadex LH-20
(CH2Cl2-MeOH 1:1) and then silica gel CC (160 g), eluted with EtOAc to yield 7 (500 mg)
and 8 (20 mg).
3.4 Characterization of compounds
Leoleorin A [(8S,9R,10S)-15,16-epoxy-9α-hydroxylabda-5,13(16), 14-trien-7-
one, 9]—white crystals (from EtOAc), mp 194-197 °C;  −22.5 (c 0.08, MeOH); UV
(MeOH) λmax (log ε) 240 (4.17) nm; IR (KBr) νmax 3612, 2943, 1654, 1519, 1463 cm−1;
for 1H and 13C NMR spectroscopic data, see Tables 1 and 2; ESIMS m/z 317.2 [M + H]+.
Leoleorin B (15,16-epoxylabda-5,8,13(16),14-tetraen-7-one, 10)—yellow oil; 
+23.9 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 245 (3.98) nm; IR (KBr) νmax 2944, 1651,
1622, 1465, 1364 cm−1; for 1H and 13C NMR spectroscopic data, see Tables 1 and 2;
ESIMS m/z 299.2 [M + H]+.
Leoleorin C (9,13-epoxy-6-hydroxylabdan-15,16-olide, 11)—white powder; 
−2.1 (c 0.8, MeOH); ESIMS m/z 695.5 [2M + Na]+; 1H and 13C NMR spectroscopic data
were identical with 9,13-epoxy-6-hydroxylabdan-16,15-olide (Naidoo et al., 2011).
Leoleorin D[(5S,6R,8R,9R,10S,13S)-9,13-epoxylabdane-6,15,16-triol, 1]—white
crystals (from EtOAc), mp 116–117 °C;  −7.5 (c 1.1, MeOH); for 1H and 13C NMR
spectroscopic data, see Tables 1 and 2; HR-ESIMS m/z 363.2499 [M + Na]+ (calcd for
C20H36O4Na, 363.2511).
Leoleorin E (9,13:15,16-diepoxylabdane-6β,15α-diol, 2)—colorless oil;  −3.3 (c
0.06, MeOH); for 1H and 13C NMR spectroscopic data, see Tables 1 and 2; HR-ESIMS m/z
361.2351 [M + Na]+ (calcd for C20H34O4Na, 361.2355).
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Leoleorin F (9,13:15,16-diepoxylabdane-6β,16β-diol, 3)—colorless oil;  −21.6
(c 0.04, MeOH); for 1H and 13C NMR spectroscopic data, see Tables 1 and 2; HR-ESIMS
m/z 361.2357 [M + Na]+ (calcd for C20H34O4Na, 361.2355).
16-epi-Leoleorin F (9,13:15,16-diepoxylabdane-6β,16α-diol, 4)—white powder;
 +30.0 (c 0.2, MeOH); for 1H and 13C NMR spectroscopic data, see Tables 1 and 2;
HR-ESIMS m/z 361.2359 [M + Na]+ (calcd for C20H34O4Na, 361.2355).
Leoleorin G (9,13-epoxylabd-5-en-7-on-15,16-olide, 5)—colorless oil;  −20.5 (c
0.4, MeOH); UV (MeOH) λmax (log ε) 233 (4.06) nm; IR (KBr) νmax 2930, 1783,
1667,1167, 1025 cm−1; for 1H and 13C NMR spectroscopic data, see Tables 1 and 2; HR-
ESIMS m/z 355.1889 [M + Na]+ (calcd for C20H28O4Na, 355.1885).
Leoleorin H (15-acetoxy-9,13-epoxy-16-hydroxylabd-5-en-7-one, 6)—white
powder;  −29.5 (c 0.4, MeOH); UV (MeOH) λmax (log ε) 234 (4.15) nm; IR (KBr)
νmax 3462, 2930, 1736, 1665, 1466, 1367, 1241 cm−1; for 1H and 13C NMR spectroscopic
data, see Tables 1 and 2; HR-ESIMS m/z 379.2468 [M + H]+ (calcd for C22H35O5,
379.2484).
Leoleorin I (9,13-epoxy-15,16-dihydroxylabd-5-en-7-one, 7)—colorless oil; 
−36.5 (c 0.06, MeOH); UV (MeOH) λmax (log ε) 240 (4.16) nm; IR (KBr) νmax 3368,
2929, 1660, 1465, 1040, 985 cm−1; for 1H and 13C NMR spectroscopic data, see Tables 1
and 2; HR-ESIMS m/z 359.2208 [M + Na]+ (calcd for C20H32O4Na, 359.2198).
Leoleorin J (9,13-epoxylabd-5-ene-7β,15,16-triol, 8)—colorless oil;  −69.6 (c
0.02, MeOH); IR (KBr) νmax 3565, 1650, 1041, 1024 cm−1; for 1H and 13C NMR
spectroscopic data, see Tables 1 and 2; HR-ESIMS m/z 361.2359 [M + Na]+ (calcd for
C20H34O4Na, 361.2355).
3.5 X-ray Crystallography
The crystal structures and absolute configuration of 1 and 9 were determined using data
collected at T = 90 K with CuKα radiation (λ = 1.54178 Å) on a Bruker APEX-II CCD
diffractometer, equipped with an Oxford Cryostream cooler. Structures were solved using
the program SHELXS-97 and refined anisotropically by full-matrix least squares on F2
using SHELXL-97 (Sheldrick, 2008). OH hydrogen coordinates were refined; other H atoms
were visible in difference maps, but were placed in idealized positions for the refinements.
The absolute configurations were determined by refinement of the Flack (Flack, 1983)
parameter based on resonant scattering of the light atoms and computation of the Hooft
parameter (Hooft et al., 2008), in both cases yielding a probability of 1.000 that the reported
configuration is correct. Crystal data: leoleorin D (1), C20H36O4, Mr = 340.49, orthorhombic
space group P212121, a = 6.9830 (3), b = 13.9703 (6), c = 19.1528 (8) Å, V = 1868.44 (14)
Å3, Z = 4, Dx = 1.210 Mg m−3, θmax = 69.4°, R = 0.027 for 3472 data and 231 refined
parameters. The Flack parameter is 0.08 (13) and the Hooft parameter is 0.04 (3) for 1452
Bijvoet pairs (98% coverage); leoleorin A (9), C20H28O3, Mr = 316.42, orthorhombic space
group P212121, a = 6.5463 (2), b = 11.4968 (4), c = 22.8194 (9) Å, V = 1717.42 (10) Å3, Z =
4, Dx = 1.224 Mg m−3, θmax = 67.6°, R = 0.030 for 3061 data and 216 refined parameters.
The Flack parameter is 0.05 (18) and the Hooft parameter is 0.00 (9) for 1265 Bijvoet pairs
(98% coverage). The crystal structures have been deposited with the Cambridge
Crystallographic Data Centre, deposition numbers CCDC 86124 for leoleorin D (1) and
CCDC 861242 for leoleorin A (9).
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3.6 Radioligand Binding Assays
Receptor binding profiles were generously provided by the National Institute of Mental
Health's Psychoactive Drug Screening Program, Contract # HHSN-271-2008-00025-C
(NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth M.D., Ph.D. at the
University of North Carolina at Chapel Hill and Project Officer Jamie Driscol at NIMH,
Bethesda MD, USA. For initial screening, compounds were tested at concentrations of
10μmol/L. Detailed receptor-binding protocols are available at their web site (http://
pdsp.med.unc.edu).
Highlights
► Eleven labdane diterpenoids were isolated from the leaves of Leonotis leonurus. ►
Eight compounds were hitherto unknown. ► All compounds were evaluated for their
binding affinities to various CNS receptors. ► Leoleorin C (11) showed weak binding
affinity (Ki = 2.9 μM) to the Sigma 1 receptor.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structures of compounds 1–11.
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ORTEP drawing of 1.
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Key NOESY correlations of 2.
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Key NOESY correlations of 3.
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Key NOESY correlations of 4.
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ORTEP drawing of 9.
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